PREPARATIVE ISOLATION OF RECOMBINANT HUMAN INSULIN-LIKE GROWTH-FACTOR-1 BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

被引:21
作者
OLSON, CV [1 ]
REIFSNYDER, DH [1 ]
CANOVADAVIS, E [1 ]
LING, VT [1 ]
BUILDER, SE [1 ]
机构
[1] GENENTECH INC,DEPT MED & ANALYT CHEM,S SAN FRANCISCO,CA 94080
关键词
D O I
10.1016/0021-9673(94)85264-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The isolation of recombinant human insulin-like growth factor 1 (rhIGF-1) is complicated by the presence of several rhIGF-1 variants which co-purify using conventional chromatographic media. These species consist primarily of a methionine-sulfoxide variant of the properly folded molecule and a misfolded form and its respective methionine-sulfoxide variant. An analytical reversed-phase high-performance liquid chromatography procedure using a 5-mu m C-18 column, an acetonitrile-trifluoroacetic acid (TFA) isocratic elution, and elevated temperature gives baseline resolution of the four species. Using this analytical method as a development tool, a process-scale chromatography step was established. The 5-mu m analytical packing material was replaced with a larger-size particle to reduce back-pressure and cost. Since the TFA counter-ion binds tightly to proteins and is difficult to subsequently dissociate, a combination of acetic acid and NaCl was substituted. Isocratic separations are not good process options due to problems with reproducibility and control. A shallow gradient elution using premixed mobile phase buffers at the same linear velocity was found to give an equivalent separation at low load levels and minimized solvent degassing. However, at higher loading there was a loss of resolution. A matrix of various buffers was evaluated for their effects on separation. Elevated pH resulted in a significant shift in both the elution order and relative retention times of the principal rh-IGF-1 variants, resulting in a substantial increase in effective capacity. An increase in the ionic strength further improved resolution. Several different media were evaluated with regard to particle size, shape and pore diameter using the improved mobile phase. The new conditions were scaled up 1305-fold and resulted in superimposable chromatograms, 96% recovery and > 99% purity. Thus, by optimizing the pH, ionic strength and temperature, a high-capacity preparative separation of rhIGF-1 from its related fermentation variants was obtained.
引用
收藏
页码:101 / 112
页数:12
相关论文
共 37 条
[1]  
Andrews A. T., 1986, ELECTROPHORESIS
[2]   THE SOMATOMEDINS - INSULIN-LIKE GROWTH-FACTORS [J].
BAXTER, RC .
ADVANCES IN CLINICAL CHEMISTRY, 1986, 25 :49-115
[3]  
Bidlingmeyer BA., 1987, PREPARATIVE LIQUID C
[4]  
BINOUX M, 1980, ANN ENDOCRINOL-PARIS, V41, P157
[5]   CHEMICAL HETEROGENEITY AS A RESULT OF HYDROXYLAMINE CLEAVAGE OF A FUSION PROTEIN OF HUMAN INSULIN-LIKE GROWTH FACTOR-I [J].
CANOVADAVIS, E ;
ENG, M ;
MUKKU, V ;
REIFSNYDER, DH ;
OLSON, CV ;
LING, VT .
BIOCHEMICAL JOURNAL, 1992, 285 :207-213
[6]   ISOLATION OF INSULIN-LIKE GROWTH FACTORS-I AND FACTORS-II FROM HUMAN-PLASMA [J].
CORNELL, HJ ;
BOUGHDADY, NM ;
HERINGTON, AC .
PREPARATIVE BIOCHEMISTRY, 1984, 14 (02) :123-138
[7]   APPLICATION OF PREPARATIVE REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY TO THE ISOLATION OF INSULIN-LIKE GROWTH-FACTOR II FROM HUMAN-SERUM [J].
CORNELL, HJ ;
BRADY, PH .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 421 (01) :61-69
[8]  
COX GB, 1988, LC GC N AM, V6, P894
[9]   SEPARATION AND CHARACTERIZATION OF MODIFIED VARIANTS OF RECOMBINANT HUMAN INSULIN-LIKE GROWTH FACTOR-I DERIVED FROM A FUSION PROTEIN SECRETED FROM ESCHERICHIA-COLI [J].
FORSBERG, G ;
PALM, G ;
EKEBACKE, A ;
JOSEPHSON, S ;
HARTMANIS, M .
BIOCHEMICAL JOURNAL, 1990, 271 (02) :357-363
[10]   SHEEP INSULIN-LIKE GROWTH FACTOR-I AND FACTOR-II - SEQUENCES, ACTIVITIES AND ASSAYS [J].
FRANCIS, GL ;
MCNEIL, KA ;
WALLACE, JC ;
BALLARD, FJ ;
OWENS, PC .
ENDOCRINOLOGY, 1989, 124 (03) :1173-1183